HCC in the Setting of Hepatitis B: Key Issues for Clinicians Providing Care for Liver Diseases

Download All
Watch 3 expert faculty in the multimedia module to learn about HCC risk assessment, screening, and surveillance in the setting of hepatitis B. Consolidate your learning with the expert-authored Clinical Focus, faculty ClinicalThought commentaries, and the companion Quick Reference Guide. Share the downloadable slides with your colleagues.
Robert S. Brown, Jr., MD, MPH
Paul Y. Kwo, MD
person default
Yasuhito Tanaka, MD, PhD
Norah Terrault Headshot
Norah Terrault, MD, MPH
Grace LH Wong, 医学博士
Grace LH Wong, MD

PDF

Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.

Robert S. Brown, Jr., MD, MPH Released: February 22, 2021

Downloadable Slideset

Gain expert insight on practical approaches to HCC risk assessment, HCC screening and surveillance, and HCC management in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault Headshot Norah Terrault, MD, MPH Released: March 26, 2021

Video Module

Watch this dynamic panel discussion on HCC risk, screening, surveillance, and management, in the setting of patients with hepatitis B.

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault Headshot Norah Terrault, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Pharmacists: 1.25 contact hours (0.125 CEUs) Released: March 26, 2021 Expired: March 25, 2022

ClinicalThought

亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项

Grace LH Wong, 医学博士 Released: April 16, 2021

Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.

Grace LH Wong, MD Released: April 15, 2021

Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?

person default Yasuhito Tanaka, MD, PhD Released: May 6, 2021

HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Clinical Focus

Learn from Grace LH Wong, MD, about prevention and treatment of HBV-related HCC in the Asia-Pacific region, where more than 75% of the global population with HBV resides.

Grace LH Wong, MD Released: June 8, 2021

In these slides, expert faculty discusses Asia-Pacific considerations relevant to patients with HCC in the setting of hepatitis B.

Grace LH Wong, MD Released: June 10, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue